BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK, Chan IH, Yin J, Lam CW, Fok TF, Nelson EA. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord. 2004;28:1257-1263. [PMID: 15278103 DOI: 10.1038/sj.ijo.0802734] [Cited by in Crossref: 186] [Cited by in F6Publishing: 175] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Radetti G, Kleon W, Stuefer J, Pittschieler K. Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging: NAFLD in obese children. Acta Paediatrica 2006;95:833-7. [DOI: 10.1111/j.1651-2227.2006.tb02349.x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
2 Benson LJ, Baer HJ, Kaelber DC. Screening for Obesity-Related Complications Among Obese Children and Adolescents: 1999-2008. Obesity 2011;19:1077-82. [DOI: 10.1038/oby.2010.277] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
3 Jacobson M. Medical Complications and Comorbidities of Pediatric Obesity. In: Sothern M, Gordon S, Kristian von Almen T, editors. Handbook of Pediatric Obesity. CRC Press; 2006. pp. 31-9. [DOI: 10.1201/9781420019117.sec2] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
4 Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease: REVIEW: PAEDIATRIC NON-ALCOHOLIC FATTY LIVER DISEASE. Alimentary Pharmacology & Therapeutics 2008;28:13-24. [DOI: 10.1111/j.1365-2036.2008.03703.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 94] [Article Influence: 6.4] [Reference Citation Analysis]
5 Arata M, Nakajima J, Nishimata S, Nagata T, Kawashima H. Nonalcoholic steatohepatitis and insulin resistance in children. World J Diabetes 2014; 5(6): 917-923 [PMID: 25512797 DOI: 10.4239/wjd.v5.i6.917] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
6 Alkhouri N, Eng K, Lopez R, Nobili V. Non-high-density lipoprotein cholesterol (non-HDL-C) levels in children with nonalcoholic fatty liver disease (NAFLD). Springerplus 2014;3:407. [PMID: 25126490 DOI: 10.1186/2193-1801-3-407] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
7 Ozsu E, Yazıcıoğlu B. Obese boys with low concentrations of high-density lipoprotein cholesterol are at greater risk of hepatosteatosis. Hormones (Athens) 2019;18:477-84. [PMID: 31754954 DOI: 10.1007/s42000-019-00152-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Moriarty-kelsey M, Daniels SR. Childhood Obesity Is the Fuel That Fires Adult Metabolic Abnormalities and Cardiovascular Disease. Childhood Obesity 2010;6:250-6. [DOI: 10.1089/chi.2010.0504] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
9 Chen JR, Chao YP, Tsai YW, Chan HJ, Wan YL, Tai DI, Tsui PH. Clinical Value of Information Entropy Compared with Deep Learning for Ultrasound Grading of Hepatic Steatosis. Entropy (Basel) 2020;22:E1006. [PMID: 33286775 DOI: 10.3390/e22091006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, Constable RT, Weiss R, Tamborlane WV, Savoye M. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab. 2006;91:4287-4294. [PMID: 16912127 DOI: 10.1210/jc.2006-1010] [Cited by in Crossref: 252] [Cited by in F6Publishing: 233] [Article Influence: 15.8] [Reference Citation Analysis]
11 Koebnick C, Getahun D, Reynolds K, Coleman KJ, Porter AH, Lawrence JM, Punyanitya M, Quinn VP, Jacobsen SJ. Trends in Nonalcoholic Fatty Liver Disease–related Hospitalizations in US Children, Adolescents, and Young Adults. Journal of Pediatric Gastroenterology & Nutrition 2009;48:597-603. [DOI: 10.1097/mpg.0b013e318192d224] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
12 Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR, Piemonte F, Marcellini M, Angulo P. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 2008;48:119-28. [PMID: 18537181 DOI: 10.1002/hep.22336] [Cited by in Crossref: 272] [Cited by in F6Publishing: 243] [Article Influence: 19.4] [Reference Citation Analysis]
13 El-Koofy NM, Anwar GM, El-Raziky MS, El-Hennawy AM, El-Mougy FM, El-Karaksy HM, Hassanin FM, Helmy HM. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children. Saudi J Gastroenterol. 2012;18:44-49. [PMID: 22249092 DOI: 10.4103/1319-3767.91738] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
14 Chang TY, Chang SH, Lin YH, Ho WC, Wang CY, Jeng WJ, Wan YL, Tsui PH. Utility of quantitative ultrasound in community screening for hepatic steatosis. Ultrasonics 2021;111:106329. [PMID: 33338730 DOI: 10.1016/j.ultras.2020.106329] [Reference Citation Analysis]
15 Vizzutti; F, Arena; U, Nobili; V, Tarquini; R, Trappoliere; M, Laffi; G, Marra; F, Pinzani M. Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD). Annals of Hepatology 2009;8:89-94. [DOI: 10.1016/s1665-2681(19)31784-3] [Cited by in Crossref: 30] [Article Influence: 2.3] [Reference Citation Analysis]
16 Friedrich RR, Caetano LC, Schiffner MD, Wagner MB, Schuch I. Design, randomization and methodology of the TriAtiva Program to reduce obesity in school children in Southern Brazil. BMC Public Health 2015;15:363. [PMID: 25887113 DOI: 10.1186/s12889-015-1727-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
17 Zhou Z, Zhang Q, Wu W, Wu S, Tsui P. Hepatic Steatosis Assessment Using Quantitative Ultrasound Parametric Imaging Based on Backscatter Envelope Statistics. Applied Sciences 2019;9:661. [DOI: 10.3390/app9040661] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
18 Must A, Hollander SA, Economos CD. Childhood obesity: a growing public health concern. Expert Review of Endocrinology & Metabolism 2014;1:233-54. [DOI: 10.1586/17446651.1.2.233] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
19 Cree-Green M, Ravi S, Carreau AM, Sewell R, Baumgartner A, Coe G, Bergman BC, Scherzinger A, Jensen T, Pyle L, Nadeau KJ. Nonalcoholic fatty liver disease in obese adolescent females is associated with multi-tissue insulin resistance and visceral adiposity markers. Metabol Open 2019;2:100011. [PMID: 32812939 DOI: 10.1016/j.metop.2019.100011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
20 Rafeey M, Mortazavi F, Mogaddasi N, Robabeh G, Ghaffari S, Hasani A. Fatty liver in children. Ther Clin Risk Manag 2009;5:371-4. [PMID: 19536316 DOI: 10.2147/tcrm.s4467] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Eslam M, Alkhouri N, Vajro P, Baumann U, Weiss R, Socha P, Marcus C, Lee WS, Kelly D, Porta G, El-Guindi MA, Alisi A, Mann JP, Mouane N, Baur LA, Dhawan A, George J. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. Lancet Gastroenterol Hepatol 2021:S2468-1253(21)00183-7. [PMID: 34364544 DOI: 10.1016/S2468-1253(21)00183-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Alisi A, Manco M, Devito R, Nobili V. Fatty Liver Disease. In: Freemark M, editor. Pediatric Obesity. New York: Springer; 2010. pp. 201-22. [DOI: 10.1007/978-1-60327-874-4_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Brunt EM, Wong VW, Nobili V, Day CP, Sookoian S, Maher JJ, Bugianesi E, Sirlin CB, Neuschwander-tetri BA, Rinella ME. Nonalcoholic fatty liver disease. Nat Rev Dis Primers 2015;1. [DOI: 10.1038/nrdp.2015.80] [Cited by in Crossref: 302] [Cited by in F6Publishing: 288] [Article Influence: 43.1] [Reference Citation Analysis]
24 Dietrich CF, Shi L, Löwe A, Dong Y, Potthoff A, Sparchez Z, Teufel A, Guth S, Koch J, Barr RG, Cui XW. Conventional ultrasound for diagnosis of hepatic steatosis is better than believed. Z Gastroenterol 2021. [PMID: 34171931 DOI: 10.1055/a-1491-1771] [Reference Citation Analysis]
25 Kiess W, Blüher S, Kapellen T, Körner A. Metabolic Syndrome in Children and Adolescents: Prevalence, Public Health Issue, and Time for Initiative. Journal of Pediatric Gastroenterology & Nutrition 2009;49:268-71. [DOI: 10.1097/mpg.0b013e31819a4e9d] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Wan Y, Tai D, Ma H, Chiang B, Chen C, Tsui P. Effects of fatty infiltration in human livers on the backscattered statistics of ultrasound imaging. Proc Inst Mech Eng H 2015;229:419-28. [DOI: 10.1177/0954411915585864] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
27 De Bruyne RM, Fitzpatrick E, Dhawan A. Fatty liver disease in children: eat now pay later. Hepatol Int. 2010;4:375-385. [PMID: 20305757 DOI: 10.1007/s12072-009-9160-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
28 Fernandes M, Ferraro A, De Azevedo R, Fagundes Neto U. Metabolic differences between male and female adolescents with non-alcoholic fatty liver disease, as detected by ultrasound: Metabolic differences between male and female adolescents. Acta Paediatrica 2010;99:1218-23. [DOI: 10.1111/j.1651-2227.2010.01774.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
29 Campos RM, de Piano A, da Silva PL, Carnier J, Sanches PL, Corgosinho FC, Masquio DC, Lazaretti-Castro M, Oyama LM, Nascimento CM. The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy. Endocrine. 2012;42:146-156. [PMID: 22315014 DOI: 10.1007/s12020-012-9613] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Pan YW, Tsai MC, Yang YJ, Chen MY, Chen SY, Chou YY. The relationship between nonalcoholic fatty liver disease and pediatric congenital hypothyroidism patients. Kaohsiung J Med Sci 2019;35:778-86. [PMID: 31400075 DOI: 10.1002/kjm2.12118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
31 Thompson MD, Cismowski MJ, Serpico M, Pusateri A, Brigstock DR. Elevation of circulating microRNA levels in obese children compared to healthy controls. Clin Obes 2017;7:216-21. [PMID: 28397375 DOI: 10.1111/cob.12192] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
32 Mohamed RZ, Jalaludin MY, Anuar Zaini A. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity. J Pediatr Endocrinol Metab 2020;33:247-53. [PMID: 31926095 DOI: 10.1515/jpem-2019-0403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Birjandi M, Ayatollahi SM, Pourahmad S, Safarpour AR. Prediction and Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) and Identification of Its Associated Factors Using the Classification Tree Method. Iran Red Crescent Med J 2016;18:e32858. [PMID: 28191344 DOI: 10.5812/ircmj.32858] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
34 Mulkern RV, Salsberg SL, Krauel MR, Ludwig DS, Voss S. A paradoxical signal intensity increase in fatty livers using opposed-phase gradient echo imaging with fat-suppression pulses. Pediatr Radiol. 2008;38:1099-1104. [PMID: 18677467 DOI: 10.1007/s00247-008-0946-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
35 Brandt S, Roos J, Inzaghi E, Kotnik P, Kovac J, Battelino T, Cianfarani S, Nobili V, Colajacomo M, Kratzer W, Denzer C, Fischer-posovszky P, Wabitsch M. Circulating levels of miR-122 and nonalcoholic fatty liver disease in pre-pubertal obese children: Circulating miR-122 in obesity and NAFLD. Pediatric Obesity 2018;13:175-82. [DOI: 10.1111/ijpo.12261] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
36 Alisi A, Manco M, Panera N, Nobili V. Association between type two diabetes and non-alcoholic fatty liver disease in youth. Annals of Hepatology 2009;8:S44-50. [DOI: 10.1016/s1665-2681(19)31826-5] [Cited by in Crossref: 23] [Article Influence: 1.8] [Reference Citation Analysis]
37 Damar Ç, Işık E, Güngör Ş. Relationship between Quantitative Sonographic Measurements and Serum Biochemical Parameters in Childhood Obesity. Pediatr Gastroenterol Hepatol Nutr 2021;24:470-82. [PMID: 34557399 DOI: 10.5223/pghn.2021.24.5.470] [Reference Citation Analysis]
38 Botton J, Heude B, Andre P, Bresson J, Ducimetiere P, Charles M. Relationship between gamma-glutamyltransferase and fat mass in a general population of 8–17 years old children. The FLVS II study. Diabetes & Metabolism 2007;33:354-9. [DOI: 10.1016/j.diabet.2007.03.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
39 Lebensztejn DM, Wojtkowska M, Skiba E, Werpachowska I, Tobolczyk J, Kaczmarski M. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease. Adv Med Sci. 2009;54:177-182. [PMID: 20022856 DOI: 10.2478/v10039-009-0047-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
40 Alavian SM, Mohammad-Alizadeh AH, Esna-Ashari F, Ardalan G, Hajarizadeh B. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures. Liver Int 2009;29:159-63. [PMID: 18492015 DOI: 10.1111/j.1478-3231.2008.01790.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
41 Lin YC, Chang PF, Hu FC, Yang WS, Chang MH, Ni YH. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children. J Pediatr. 2011;158:740-744. [PMID: 21168155 DOI: 10.1016/j.jpeds.2010.11.016] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 5.0] [Reference Citation Analysis]
42 Charatcharoenwitthaya P, Lindor KD. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis. 2007;11:37-54, viii. [PMID: 17544971 DOI: 10.1016/j.cld.2007.02.014] [Cited by in Crossref: 127] [Cited by in F6Publishing: 115] [Article Influence: 8.5] [Reference Citation Analysis]
43 Tsai PY, Yen CJ, Li YC, Chiu TY, Chen CY, Jan CF. Association between abnormal liver function and risk factors for metabolic syndrome among freshmen. J Adolesc Health. 2007;41:132-137. [PMID: 17659216 DOI: 10.1016/j.jadohealth.2007.03.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
44 Kelishadi R, Cook SR, Adibi A, Faghihimani Z, Ghatrehsamani S, Beihaghi A, Salehi H, Khavarian N, Poursafa P. Association of the components of the metabolic syndrome with non-alcoholic fatty liver disease among normal-weight, overweight and obese children and adolescents. Diabetol Metab Syndr 2009;1:29. [PMID: 20028551 DOI: 10.1186/1758-5996-1-29] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
45 Pacifico L, Poggiogalle E, Cantisani V, Menichini G, Ricci P, Ferraro F, Chiesa C. Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge. World J Hepatol 2010; 2(7): 275-288 [PMID: 21161009 DOI: 10.4254/wjh.v2.i7.275] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
46 Sun Q, Li M, Yang X, Xu X, Wang J, Zhang J. Dietary salecan reverts partially the metabolic gene expressions and NMR-based metabolomic profiles from high-fat-diet-induced obese rats. The Journal of Nutritional Biochemistry 2017;47:53-62. [DOI: 10.1016/j.jnutbio.2017.04.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
47 Mortensen A, Lenz K, Abildstrøm H, Lauritsen TL. Anesthetizing the obese child. Paediatr Anaesth 2011;21:623-9. [PMID: 21429056 DOI: 10.1111/j.1460-9592.2011.03559.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
48 do Nascimento JH, Epifanio M, Soder RB, Baldisserotto M. MRI-diagnosed nonalcoholic fatty liver disease is correlated to insulin resistance in adolescents. Acad Radiol 2013;20:1436-42. [PMID: 24119357 DOI: 10.1016/j.acra.2013.08.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
49 Moore JB. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. Proc Nutr Soc 2010;69:211-20. [DOI: 10.1017/s0029665110000030] [Cited by in Crossref: 141] [Cited by in F6Publishing: 68] [Article Influence: 11.8] [Reference Citation Analysis]
50 Nobili V, Manco M. Therapeutic strategies for pediatric non-alcoholic fatty liver disease: A challenge for health care providers. World J Gastroenterol 2007; 13(18): 2639-2641 [PMID: 17552019 DOI: 10.3748/wjg.v13.i18.2639] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
51 Lin YC, Chang PF, Yeh SJ, Liu K, Chen HC. Risk factors for liver steatosis in obese children and adolescents. Pediatr Neonatol. 2010;51:149-154. [PMID: 20675238 DOI: 10.1016/s1875-9572(10)60028-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
52 Frelut M, Emery-fillon N, Guilland J, Dao HH, de Courcy GP. Alanine Amino Transferase Concentrations Are Linked to Folate Intakes and Methylenetetrahydrofolate Reductase Polymorphism in Obese Adolescent Girls. Journal of Pediatric Gastroenterology & Nutrition 2006;43:234-9. [DOI: 10.1097/01.mpg.0000228110.83616.92] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
53 Kwon KA, Chun P, Park JH. Clinical significance of serum alanine aminotransferase and lifestyle intervention in children with nonalcoholic fatty liver disease. Korean J Pediatr 2016;59:362-7. [PMID: 27721840 DOI: 10.3345/kjp.2016.59.9.362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
54 Manti S, Romano C, Chirico V, Filippelli M, Cuppari C, Loddo I, Salpietro C, Arrigo T. Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic “mal-programming”. Hepat Mon. 2014;14:e17641. [PMID: 24829591 DOI: 10.5812/hepatmon.17641] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
55 Tominaga K, Fujimoto E, Suzuki K, Hayashi M, Ichikawa M, Inaba Y. Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference. Environ Health Prev Med 2009;14:142-9. [PMID: 19568858 DOI: 10.1007/s12199-008-0074-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
56 Fonvig CE, Chabanova E, Andersson EA, Ohrt JD, Pedersen O, Hansen T, Thomsen HS, Holm JC. 1H-MRS Measured Ectopic Fat in Liver and Muscle in Danish Lean and Obese Children and Adolescents. PLoS One 2015;10:e0135018. [PMID: 26252778 DOI: 10.1371/journal.pone.0135018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
57 Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. The American Journal of Clinical Nutrition 2007;86:285-300. [DOI: 10.1093/ajcn/86.2.285] [Cited by in Crossref: 256] [Cited by in F6Publishing: 236] [Article Influence: 17.1] [Reference Citation Analysis]
58 Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009;58:1538-44. [PMID: 19625277 DOI: 10.1136/gut.2008.171280] [Cited by in Crossref: 414] [Cited by in F6Publishing: 389] [Article Influence: 31.8] [Reference Citation Analysis]
59 Shavakhi A, Torki M, Khodadoostan M, Shavakhi S. Effects of cumin on nonalcoholic steatohepatitis: A double blind, randomised, controlled trial. Adv Biomed Res 2015;4:212. [PMID: 26605241 DOI: 10.4103/2277-9175.166149] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
60 Wang R, Lu Q, Feng J, Yin F, Qin C, Liu B, Liu Y, Liu X. Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males. Endocrine. 2012;41:70-75. [PMID: 21796479 DOI: 10.1007/s12020-011-9511-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
61 Mathur P, Das MK, Arora NK. Non-alcoholic fatty liver disease and childhood obesity. Indian J Pediatr 2007;74:401-8. [DOI: 10.1007/s12098-007-0068-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
62 Ramírez-Vélez R, Izquierdo M, Correa-Bautista JE, Correa-Rodríguez M, Schmidt-RioValle J, González-Jiménez E, González-Jiménez K. Liver Fat Content and Body Fat Distribution in Youths with Excess Adiposity. J Clin Med 2018;7:E528. [PMID: 30544632 DOI: 10.3390/jcm7120528] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
63 Krstic J, Galhuber M, Schulz TJ, Schupp M, Prokesch A. p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine. Int J Mol Sci 2018;19:E921. [PMID: 29558460 DOI: 10.3390/ijms19030921] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
64 Lobstein T, Baur LA, Jackson-leach R. The Childhood Obesity Epidemic. In: Waters E, Swinburn BA, Seidell JC, Uauy R, editors. Preventing Childhood Obesity. Oxford: Wiley-Blackwell; 2010. pp. 3-14. [DOI: 10.1002/9781444318517.ch1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
65 Elmaoğulları S, Tepe D, Uçaktürk SA, Karaca Kara F, Demirel F. Prevalence of Dyslipidemia and Associated Factors in Obese Children and Adolescents. J Clin Res Pediatr Endocrinol 2015;7:228-34. [PMID: 26831558 DOI: 10.4274/jcrpe.1867] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
66 Alisi A, Manco M, Vania A, Nobili V. Pediatric Nonalcoholic Fatty Liver Disease in 2009. The Journal of Pediatrics 2009;155:469-74. [DOI: 10.1016/j.jpeds.2009.06.014] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 6.6] [Reference Citation Analysis]
67 Mager DR, Roberts EA. Nonalcoholic Fatty Liver Disease in Children. Clinics in Liver Disease 2006;10:109-31. [DOI: 10.1016/j.cld.2005.10.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
68 Campos RMS, de Piano A, da Silva PL, Carnier J, Sanches PL, Corgosinho FC, Masquio DCL, Lazaretti-castro M, Oyama LM, Nascimento CMO, Tock L, de Mello MT, Tufik S, Dâmaso AR. The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy. Endocrine 2012;42:146-56. [DOI: 10.1007/s12020-012-9613-3] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
69 Rhodes LA, Grainger AJ, Keenan AM, Thomas C, Emery P, Conaghan PG. The validation of simple scoring methods for evaluating compartment-specific synovitis detected by MRI in knee osteoarthritis. Rheumatology (Oxford) 2005;44:1569-73. [PMID: 16188949 DOI: 10.1093/rheumatology/kei094] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
70 Alisi A, Feldstein AE, Villani A, Raponi M, Nobili V. Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. Nat Rev Gastroenterol Hepatol 2012;9:152-61. [DOI: 10.1038/nrgastro.2011.273] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 7.1] [Reference Citation Analysis]
71 Giannini C, Polidori N, Saltarelli MA, Chiarelli F, Basilico R, Mohn A. Increased hepcidin levels and non-alcoholic fatty liver disease in obese prepubertal children: a further piece to the complex puzzle of metabolic derangements. J Pediatr Endocrinol Metab 2021. [PMID: 34726357 DOI: 10.1515/jpem-2021-0070] [Reference Citation Analysis]
72 Hsu E, Murray K. Is nonalcoholic fatty liver disease in children the same disease as in adults? Clin Liver Dis 2012;16:587-98. [PMID: 22824482 DOI: 10.1016/j.cld.2012.05.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
73 Chen S, Guo X, Yu S, Zhou Y, Li Z, Sun Y. Anthropometric Indices in Adults: Which Is the Best Indicator to Identify Alanine Aminotransferase Levels? Int J Environ Res Public Health 2016;13:226. [PMID: 26901214 DOI: 10.3390/ijerph13020226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
74 Doolen J, Alpert PT, Miller SK. Parental disconnect between perceived and actual weight status of children: a metasynthesis of the current research. J Am Acad Nurse Pract 2009;21:160-6. [PMID: 19302692 DOI: 10.1111/j.1745-7599.2008.00382.x] [Cited by in Crossref: 162] [Cited by in F6Publishing: 154] [Article Influence: 12.5] [Reference Citation Analysis]
75 Iraji H, Minasian V, Kelishadi R. Changes in Liver Enzymes and Metabolic Profile in Adolescents with Fatty Liver following Exercise Interventions. Pediatr Gastroenterol Hepatol Nutr 2021;24:54-64. [PMID: 33505894 DOI: 10.5223/pghn.2021.24.1.54] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
76 Zhou Z, Fang J, Cristea A, Lin Y, Tsai Y, Wan Y, Yeow K, Ho M, Tsui P. Value of homodyned K distribution in ultrasound parametric imaging of hepatic steatosis: An animal study. Ultrasonics 2020;101:106001. [DOI: 10.1016/j.ultras.2019.106001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
77 El-karaksy HM, El-raziky MS, Fouad HM, Anwar GM, El-mougy FM, El-koofy NM, El-hennawy AM. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2015;9:114-9. [DOI: 10.1016/j.dsx.2013.10.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
78 Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A, Fruhwirth R, Marcellini M, Pinzani M. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 2008;48:442-8. [PMID: 18563842 DOI: 10.1002/hep.22376] [Cited by in Crossref: 266] [Cited by in F6Publishing: 239] [Article Influence: 19.0] [Reference Citation Analysis]
79 Denzer C, Thiere D, Muche R, Koenig W, Mayer H, Kratzer W, Wabitsch M. Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. J Clin Endocrinol Metab. 2009;94:3872-3881. [PMID: 19773396 DOI: 10.1210/jc.2009-1125] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 6.2] [Reference Citation Analysis]
80 Tsui P, Wan Y. Effects of Fatty Infiltration of the Liver on the Shannon Entropy of Ultrasound Backscattered Signals. Entropy 2016;18:341. [DOI: 10.3390/e18090341] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
81 Huang SC, Yang YJ. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level. J Pediatr Gastroenterol Nutr 2013;56:145-50. [PMID: 22983378 DOI: 10.1097/MPG.0b013e3182722aee] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
82 Widhalm K, Ghods E. Nonalcoholic fatty liver disease: a challenge for pediatricians. Int J Obes 2010;34:1451-67. [DOI: 10.1038/ijo.2010.185] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
83 Chang PF, Lin YC, Liu K, Yeh SJ, Ni YH. Heme oxygenase-1 gene promoter polymorphism and the risk of pediatric nonalcoholic fatty liver disease. Int J Obes (Lond). 2015;39:1236-1240. [PMID: 25835554 DOI: 10.1038/ijo.2015.46] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
84 Roberts EA. Non-alcoholic steatohepatitis in children. Clin Liver Dis. 2007;11:155-172, x. [PMID: 17544977 DOI: 10.1016/j.cld.2007.02.008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
85 Alkhouri N, Mansoor S, Giammaria P, Liccardo D, Lopez R, Nobili V. The development of the pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver disease. PLoS One. 2014;9:e104558. [PMID: 25121514 DOI: 10.1371/journal.pone.0104558] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
86 Akcam M, Boyaci A, Pirgon O, Koroglu M, Dundar BN. Importance of the liver ultrasound scores in pubertal obese children with nonalcoholic fatty liver disease. Clin Imaging 2013;37:504-8. [PMID: 23601769 DOI: 10.1016/j.clinimag.2012.07.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
87 Akın L, Kurtoglu S, Yikilmaz A, Kendirci M, Elmalı F, Mazicioglu M. Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation. Acta Paediatr 2013;102:e107-13. [DOI: 10.1111/apa.12099] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
88 Larrieta-carrasco E, León-mimila P, Villarreal-molina T, Villamil-ramírez H, Romero-hidalgo S, Jacobo-albavera L, Gutiérrez-vidal R, López-contreras BE, Guillén-pineda LE, Sánchez-muñoz F, Bojalil R, Mejía-domínguez AM, Méndez-sánchez N, Domínguez-lópez A, Aguilar-salinas CA, Canizales-quinteros S. Association of the I148M/PNPLA3 variant with elevated alanine transaminase levels in normal-weight and overweight/obese Mexican children. Gene 2013;520:185-8. [DOI: 10.1016/j.gene.2013.03.038] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
89 Carrillo-Iregui A, Lopez-Mitnik G, Cossio S, Garibay-Nieto N, Arheart KL, Messiah SE. Relationship between aminotransferases levels and components of the metabolic syndrome among multiethnic adolescents. J Pediatr Endocrinol Metab 2010;23:1253-61. [PMID: 21714459 DOI: 10.1515/jpem.2010.199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
90 Gupta R, Bhangoo A, Matthews NA, Anhalt H, Matta Y, Lamichhane B, Malik S, Narwal S, Wetzler G, Ten S. The prevalence of non-alcoholic fatty liver disease and metabolic syndrome in obese children. J Pediatr Endocrinol Metab. 2011;24:907-911. [PMID: 22308841 DOI: 10.1515/jpem.2011.282] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
91 Ferrajolo C, Verhamme KM, Trifirò G, ‘t Jong GW, Giaquinto C, Picelli G, Oteri A, de Bie S, Valkhoff VE, Schuemie MJ. Idiopathic acute liver injury in paediatric outpatients: incidence and signal detection in two European countries. Drug Saf. 2013;36:1007-1016. [PMID: 23591830 DOI: 10.1007/s40264-013-0045-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
92 Salvatore D, Satnick A, Abell R, Messina CR, Chawla A. The prevalence of abnormal metabolic parameters in obese and overweight children. JPEN J Parenter Enteral Nutr 2014;38:852-5. [PMID: 23851425 DOI: 10.1177/0148607113496820] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
93 Kelishadi R, Poursafa P. Obesity and air pollution: global risk factors for pediatric non-alcoholic fatty liver disease. Hepat Mon 2011;11:794-802. [PMID: 22224077 DOI: 10.5812/kowsar.1735143X.746] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
94 Neef M, Weise S, Adler M, Sergeyev E, Dittrich K, Körner A, Kiess W. Health impact in children and adolescents. Best Practice & Research Clinical Endocrinology & Metabolism 2013;27:229-38. [DOI: 10.1016/j.beem.2013.02.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
95 Quirós-Tejeira RE, Rivera CA, Ziba TT, Mehta N, Smith CW, Butte NF. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI & gt; or =95th percentile. J Pediatr Gastroenterol Nutr. 2007;44:228-236. [PMID: 17255837 DOI: 10.1097/mpg.0b013e31802d4acc] [Cited by in Crossref: 79] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
96 Pacifico L, Celestre M, Anania C, Paolantonio P, Chiesa C, Laghi A. MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr. 2007;96:542-547. [PMID: 17306008 DOI: 10.1111/j.1651-2227.2007.00186.x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 86] [Article Influence: 6.0] [Reference Citation Analysis]
97 Barshop NJ, Francis CS, Schwimmer JB, Lavine JE. Nonalcoholic fatty liver disease as a comorbidity of childhood obesity. Ped Health. 2009;3:271-281. [PMID: 20556232 DOI: 10.2217/phe.09.21] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
98 Papandreou D, Rousso I, Mavromichalis I. Update on non-alcoholic fatty liver disease in children. Clinical Nutrition 2007;26:409-15. [DOI: 10.1016/j.clnu.2007.02.002] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 5.1] [Reference Citation Analysis]
99 Kelishadi R, Poursafa P. Obesity and Air Pollution: Global Risk Factors for Pediatric Non-alcoholic Fatty Liver Disease. Hepat Mon 2011;11:794-802. [DOI: 10.5812/kowsar.1735143x.1104] [Cited by in Crossref: 22] [Article Influence: 2.0] [Reference Citation Analysis]
100 Braunersreuther V, Viviani GL, Mach F, Montecucco F. Role of cytokines and chemokines in non-alcoholic fatty liver disease. World J Gastroenterol 2012; 18(8): 727-735 [PMID: 22371632 DOI: 10.3748/wjg.v18.i8.727] [Cited by in CrossRef: 193] [Cited by in F6Publishing: 177] [Article Influence: 19.3] [Reference Citation Analysis]
101 Körner A, Kratzsch J, Gausche R, Blüher S, Kapellen T, Pulzer F, Behrens M, Kiess W. Metabolic syndrome in children and adolescents – risk for sleep-disordered breathing and obstructive sleep-apnoea syndrome? Archives of Physiology and Biochemistry 2008;114:237-43. [DOI: 10.1080/13813450802306685] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
102 Fermin CR, Lee AM, Filipp SL, Gurka MJ, DeBoer MD. Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014. Metab Syndr Relat Disord 2017;15:276-82. [PMID: 28520503 DOI: 10.1089/met.2017.0023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
103 Chan DFY, So HK, Hui SCN, Chan RSM, Li AM, Sea MM, Chu WCW, Chan M, Woo J, Nelson EAS. Dietitian-led lifestyle modification programme for obese Chinese adolescents with non-alcoholic fatty liver disease: a randomized controlled study. Int J Obes (Lond) 2018;42:1680-90. [PMID: 29453464 DOI: 10.1038/s41366-018-0010-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
104 Mandato C, Lucariello S, Licenziati MR, Franzese A, Spagnuolo MI, Ficarella R, Pacilio M, Amitrano M, Capuano G, Meli R. Metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease. J Pediatr. 2005;147:62-66. [PMID: 16027697 DOI: 10.1016/j.jpeds.2005.02.028] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 3.2] [Reference Citation Analysis]
105 Navarro-jarabo JM, Ubiña-aznar E, Tapia-ceballos L, Ortiz-cuevas C, Pérez-aísa MA, Rivas-ruiz F, Andrade RJ, Perea-milla E. Hepatic steatosis and severity-related factors in obese children: Hepatic steatosis in obese children. J Gastroenterol Hepatol 2013;28:1532-8. [DOI: 10.1111/jgh.12276] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
106 Pacifico L, Nobili V, Anania C, Verdecchia P, Chiesa C. Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. World J Gastroenterol 2011; 17(26): 3082-3091 [PMID: 21912450 DOI: 10.3748/wjg.v17.i26.3082] [Cited by in F6Publishing: 54] [Reference Citation Analysis]
107 Ahima RS. The natural history of nonalcoholic fatty liver disease: insights from children and mice. Gastroenterology 2008;135:1860-2. [PMID: 19000676 DOI: 10.1053/j.gastro.2008.11.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
108 López-capapé M, López-bermejo A, Alonso Blanco M, Lara Orejas E, Corbatón Blasco J, Barrio Castellanos R. Esteatosis hepática, resistencia a la insulina y adiponectina en una población con obesidad. Anales de Pediatría 2009;71:495-501. [DOI: 10.1016/j.anpedi.2009.07.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
109 Tsui PH, Zhou Z, Lin YH, Hung CM, Chung SJ, Wan YL. Effect of ultrasound frequency on the Nakagami statistics of human liver tissues. PLoS One 2017;12:e0181789. [PMID: 28763461 DOI: 10.1371/journal.pone.0181789] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
110 Jimenez-Rivera C, Hadjiyannakis S, Davila J, Hurteau J, Aglipay M, Barrowman N, Adamo KB. Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity. BMC Pediatr 2017;17:113. [PMID: 28446162 DOI: 10.1186/s12887-017-0867-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
111 Alkhouri N, Sedki E, Alisi A, Lopez R, Pinzani M, Feldstein AE, Nobili V. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease. Liver Int. 2013;33:79-85. [PMID: 23146095 DOI: 10.1111/liv.12024] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 5.9] [Reference Citation Analysis]
112 Atabek ME, Selver Eklioglu B, Akyürek N. Which metabolic syndrome criteria best predict non-alcoholic fatty liver disease in children? Eat Weight Disord 2014;19:495-501. [PMID: 24844310 DOI: 10.1007/s40519-014-0129-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
113 Papandreou D, Rousso I, Economou I, Makedou A, Moudiou T, Malindretos P, Pidonia I, Pantoleon A, Mavromichalis I. Is there any association between high-density lipoprotein, insulin resistance and non-alcoholic fatty liver disease in obese children? Int J Food Sci Nutr 2009;60:312-8. [PMID: 18608565 DOI: 10.1080/09637480701780088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
114 Yu EL, Golshan S, Harlow KE, Angeles JE, Durelle J, Goyal NP, Newton KP, Sawh MC, Hooker J, Sy EZ, Middleton MS, Sirlin CB, Schwimmer JB. Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity. J Pediatr 2019;207:64-70. [PMID: 30559024 DOI: 10.1016/j.jpeds.2018.11.021] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 13.3] [Reference Citation Analysis]
115 Manco M, Bottazzo G, Devito R, Marcellini M, Mingrone G, Nobili V. Nonalcoholic Fatty Liver Disease in Children. Journal of the American College of Nutrition 2008;27:667-76. [DOI: 10.1080/07315724.2008.10719744] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
116 Atsawarungruangkit A, Elfanagely Y, Pan J, Anderson K, Scharfen J, Promrat K. Prevalence and risk factors of steatosis and advanced fibrosis using transient elastography in the United States’ adolescent population. World J Hepatol 2021; 13(7): 790-803 [PMID: 34367500 DOI: 10.4254/wjh.v13.i7.790] [Reference Citation Analysis]
117 Malespin M, Sleesman B, Lau A, Wong SS, Cotler SJ. Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese American children. J Clin Gastroenterol 2015;49:345-9. [PMID: 24667593 DOI: 10.1097/MCG.0000000000000121] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
118 Lin YC, Chang PF, Chang MH, Ni YH. A common variant in the peroxisome proliferator-activated receptor-γ coactivator-1α gene is associated with nonalcoholic fatty liver disease in obese children. Am J Clin Nutr. 2013;97:326-331. [PMID: 23269818 DOI: 10.3945/ajcn.112.046417] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
119 González Jiménez E, Schmidt Río-Valle J, Álvarez Ferre J. [Fatty liver and its clinical management in obese adolescents]. Endocrinol Nutr 2011;58:32-7. [PMID: 21216209 DOI: 10.1016/j.endonu.2010.10.005] [Reference Citation Analysis]
120 Devadason CA, Scheimann AO. Overview of screening methods for fatty liver disease in children. World J Hepatol 2012; 4(1): 1-4 [PMID: 22312449 DOI: 10.4254/wjh.v4.i1.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
121 Pall H, Jonas MM. Pediatric hepatobiliary disease: . Current Opinion in Gastroenterology 2005;21:344-7. [DOI: 10.1097/01.mog.0000158112.59463.f7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
122 Takahashi Y, Fukusato T. Pediatric nonalcoholic fatty liver disease: Overview with emphasis on histology. World J Gastroenterol 2010; 16(42): 5280-5285 [PMID: 21072890 DOI: 10.3748/wjg.v16.i42.5280] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
123 Lin YC, Chang PF, Chang MH, Ni YH. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals. Am J Clin Nutr. 2014;99:869-874. [PMID: 24477042 DOI: 10.3945/ajcn.113.079749] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 8.0] [Reference Citation Analysis]
124 Nobili V, Alkhouri N, Alisi A, Ottino S, Lopez R, Manco M, Feldstein AE. Retinol-Binding Protein 4: A Promising Circulating Marker of Liver Damage in Pediatric Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology 2009;7:575-9. [DOI: 10.1016/j.cgh.2008.12.031] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
125 Delvin E, Patey N, Dubois J, Henderson M, Lévy É. Pediatric Non-Alcoholic Fatty Liver Disease. J Med Biochem 2015;34:3-12. [PMID: 28356817 DOI: 10.2478/jomb-2014-0059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
126 Rocha R, Cotrim HP, Bitencourt AGV, Barbosa DBV, Santos AS, Almeida AM, Cunha B, Guimarães I. Nonalcoholic fatty liver disease in asymptomatic Brazilian adolescents. World J Gastroenterol 2009; 15(4): 473-477 [PMID: 19152453 DOI: 10.3748/wjg.15.473] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
127 Lin YC, Chang PF, Lin HF, Liu K, Chang MH, Ni YH. Variants in the autophagy-related gene IRGM confer susceptibility to non-alcoholic fatty liver disease by modulating lipophagy. J Hepatol 2016;65:1209-16. [PMID: 27417217 DOI: 10.1016/j.jhep.2016.06.029] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 6.5] [Reference Citation Analysis]
128 Giorgio V, Prono F, Graziano F, Nobili V. Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. BMC Pediatr. 2013;13:40. [PMID: 23530957 DOI: 10.1186/1471-2431-13-40] [Cited by in Crossref: 95] [Cited by in F6Publishing: 89] [Article Influence: 10.6] [Reference Citation Analysis]
129 Lee YS, Kek BL, Poh LK, Saw SM, Loke KY. Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children. J Pediatr Gastroenterol Nutr 2008;47:172-8. [PMID: 18664869 DOI: 10.1097/MPG.0b013e318162a0e5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
130 Zou ZY, Zeng J, Ren TY, Huang LJ, Wang MY, Shi YW, Yang RX, Zhang QR, Fan JG. The burden and sexual dimorphism with nonalcoholic fatty liver disease in Asian children: A systematic review and meta-analysis. Liver Int 2021. [PMID: 34619026 DOI: 10.1111/liv.15080] [Reference Citation Analysis]
131 Ciba I, Widhalm K. The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents. Acta Paediatr 2007;96:109-12. [PMID: 17187615 DOI: 10.1111/j.1651-2227.2007.00031.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
132 Rinaldi AE, Pimentel GD, Pereira AF, Gabriel GF, Moreto F, Burini RC. Metabolic syndrome in overweight children from the city of Botucatu - São Paulo State - Brazil: agreement among six diagnostic criteria. Diabetol Metab Syndr 2010;2:39. [PMID: 20529375 DOI: 10.1186/1758-5996-2-39] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
133 Benetolo PO, Fernandes MIM, Ciampo IRLD, Elias-Junior J, Sawamura R. Evaluation of nonalcoholic fatty liver disease using magnetic resonance in obese children and adolescents. J Pediatr (Rio J). 2019;95:34-40. [PMID: 29438686 DOI: 10.1016/j.jped.2017.12.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
134 Denzer C. [Non-alcoholic fatty liver disease in obese children and adolescents]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013;56:517-27. [PMID: 23529597 DOI: 10.1007/s00103-012-1639-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
135 Baumann U. Obelix and the trouble of fatty liver disease in childhood: ‘I never knew anyone could get liver trouble’Obelix in ‘ Asterix and the Chieftain's Shield’. Pract Diab Int 2007;24:292-4. [DOI: 10.1002/pdi.1123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
136 Ma H, Zhou Z, Wu S, Wan Y, Tsui P. A Computer-Aided Diagnosis Scheme For Detection Of Fatty Liver In Vivo Based On Ultrasound Kurtosis Imaging. J Med Syst 2016;40. [DOI: 10.1007/s10916-015-0395-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
137 Corte CD, Ferrari F, Villani A, Nobili V. Epidemiology and Natural History of NAFLD. J Med Biochem 2015;34:13-7. [PMID: 28356818 DOI: 10.2478/jomb-2014-0049] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
138 D'adamo E, Impicciatore M, Capanna R, Marcovecchio ML, Masuccio FG, Chiarelli F, Mohn AA. Liver Steatosis in Obese Prepubertal Children: A Possible Role of Insulin Resistance. Obesity 2008;16:677-83. [DOI: 10.1038/oby.2007.122] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
139 Kao J, Wang J, Hung C, Hu T, Lee C, Hung S, Lu S. Changing aetiology of liver dysfunction in the new generation of a hepatitis B and C-endemic area: cross-sectional studies on adolescents born in the first 10 years after universal hepatitis B vaccination: Aetiological change in a hepatitis area. Liver International 2008;28:1298-304. [DOI: 10.1111/j.1478-3231.2008.01844.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
140 Saki F, Karamizadeh Z. Metabolic syndrome, insulin resistance and Fatty liver in obese Iranian children. Iran Red Crescent Med J 2014;16:e6656. [PMID: 25031864 DOI: 10.5812/ircmj.6656] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
141 Trivedi S, Burton A, Oden J. Management of pediatric obesity: a lifestyle modification approach. Indian J Pediatr 2014;81:152-7. [PMID: 23893368 DOI: 10.1007/s12098-013-1138-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
142 Sert A, Pirgon O, Aypar E, Yılmaz H, Dündar B. Relationship between aspartate aminotransferase-to-platelet ratio index and carotid intima-media thickness in obese adolescents with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol 2013;5:182-8. [PMID: 24072087 DOI: 10.4274/Jcrpe.891] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
143 Lin YC, Chang PF, Chang MH, Ni YH. Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children. Liver Int 2018;38:1300-7. [PMID: 29314568 DOI: 10.1111/liv.13689] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
144 Körner A, Kratzsch J, Gausche R, Schaab M, Erbs S, Kiess W. New Predictors of the Metabolic Syndrome in Children—Role of Adipocytokines. Pediatr Res 2007;61:640-5. [DOI: 10.1203/01.pdr.0000262638.48304.ef] [Cited by in Crossref: 110] [Cited by in F6Publishing: 94] [Article Influence: 7.3] [Reference Citation Analysis]
145 Chanu Thounaojam M, Navalsinh Jadeja R, Devkar RV, Vadathala Ramachandran A. Non-alcoholic steatohepatitis: an overview including treatments with herbals as alternative therapeutics. J Appl Biomed 2012;10:119-36. [DOI: 10.2478/v10136-012-0008-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
146 Hamza RT, Elkabbany ZA, Shedid AM, Hamed AI, Ebrahim AO. Serum Chemerin in Obese Children and Adolescents Before and After L-Carnitine Therapy: Relation to Nonalcoholic Fatty Liver Disease and Other Features of Metabolic Syndrome. Archives of Medical Research 2016;47:541-9. [DOI: 10.1016/j.arcmed.2016.11.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
147 Nobili V, Reale A, Alisi A, Morino G, Trenta I, Pisani M, Marcellini M, Raucci U. Elevated serum ALT in children presenting to the emergency unit: Relationship with NAFLD. Digestive and Liver Disease 2009;41:749-52. [DOI: 10.1016/j.dld.2009.02.048] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
148 Alqahtani A, Elahmedi M, Alswat K, Arafah M, Fagih M, Lee J. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy. Surg Obes Relat Dis. 2017;13:1599-1609. [PMID: 28600116 DOI: 10.1016/j.soard.2017.04.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
149 Nobili V, Parkes J, Bottazzo G, Marcellini M, Cross R, Newman D, Vizzutti F, Pinzani M, Rosenberg WM. Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease. Gastroenterology 2009;136:160-7. [DOI: 10.1053/j.gastro.2008.09.013] [Cited by in Crossref: 173] [Cited by in F6Publishing: 163] [Article Influence: 13.3] [Reference Citation Analysis]
150 Ozkol M, Ersoy B, Kasirga E, Taneli F, Bostanci IE, Ozhan B. Metabolic predictors for early identification of fatty liver using doppler and B-mode ultrasonography in overweight and obese adolescents. Eur J Pediatr 2010;169:1345-52. [DOI: 10.1007/s00431-010-1227-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
151 Tsuruta G, Tanaka N, Hongo M, Komatsu M, Horiuchi A, Hamamoto K, Iguchi C, Nakayama Y, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Aoyama T, Tanaka E. Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits. J Gastroenterol. 2010;45:666-672. [PMID: 20084525 DOI: 10.1007/s00535-009-0198-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
152 Luo J, Xu L, Li J, Zhao S. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease. Eur J Gastroenterol Hepatol. 2015;27:193-199. [PMID: 25563143 DOI: 10.1097/meg.0000000000000254] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 5.1] [Reference Citation Analysis]
153 Grefhorst A, van de Peppel IP, Larsen LE, Jonker JW, Holleboom AG. The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease. Front Endocrinol (Lausanne) 2020;11:601627. [PMID: 33597924 DOI: 10.3389/fendo.2020.601627] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
154 Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr. 2006;43:413-427. [PMID: 17033514 DOI: 10.1097/01.mpg.0000239995.58388.56] [Cited by in Crossref: 164] [Cited by in F6Publishing: 150] [Article Influence: 10.3] [Reference Citation Analysis]
155 Graham RC, Burke A, Stettler N. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents. J Pediatr Gastroenterol Nutr. 2009;49:442-449. [PMID: 19644391 DOI: 10.1097/mpg.0b013e31819f73b4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
156 do Nascimento JH, Soder RB, Epifanio M, Baldisserotto M. Accuracy of computer-aided ultrasound as compared with magnetic resonance imaging in the evaluation of nonalcoholic fatty liver disease in obese and eutrophic adolescents. Radiol Bras 2015;48:225-32. [PMID: 26379321 DOI: 10.1590/0100-3984.2014.0074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
157 Sartorio A, Del Col A, Agosti F, Mazzilli G, Bellentani S, Tiribelli C, Bedogni G. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr. 2007;61:877-883. [PMID: 17151586 DOI: 10.1038/sj.ejcn.1602588] [Cited by in Crossref: 114] [Cited by in F6Publishing: 112] [Article Influence: 7.1] [Reference Citation Analysis]
158 Ochiai H, Shirasawa T, Nishimura R, Nanri H, Ohtsu T, Hoshino H, Tajima N, Kokaze A. Waist-to-height ratio is more closely associated with alanine aminotransferase levels than body mass index and waist circumference among population-based children: a cross-sectional study in Japan. BMC Pediatr 2015;15:59. [PMID: 25980380 DOI: 10.1186/s12887-015-0378-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
159 Boyraz M, Hatipoğlu N, Sarı E, Akçay A, Taşkın N, Ulucan K, Akçay T. Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria. Obesity Research & Clinical Practice 2014;8:e356-63. [DOI: 10.1016/j.orcp.2013.08.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
160 Levine JA. Obesity in China: Causes and solutions: . Chinese Medical Journal 2008;121:1043-50. [DOI: 10.1097/00029330-200806010-00015] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
161 Wieckowska A, Feldstein AE. Nonalcoholic fatty liver disease in the pediatric population: a review. Curr Opin Pediatr. 2005;17:636-641. [PMID: 16160540 DOI: 10.1097/01.mop.0000172816.79637.c5] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 5.3] [Reference Citation Analysis]
162 Lin YC, Chang PF, Liu K, Chang MH, Ni YH. Predictors for incidence and remission of nonalcoholic fatty liver disease in obese children and adolescents. J Formos Med Assoc 2021:S0929-6646(21)00021-8. [PMID: 33504463 DOI: 10.1016/j.jfma.2021.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
163 Pirgon O, Bilgin H, Tolu I, Odabas D. Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf). 2011;75:189-195. [PMID: 21521307 DOI: 10.1111/j.1365-2265.2011.04038.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
164 Sagi R, Reif S, Neuman G, Webb M, Phillip M, Shalitin S. Nonalcoholic fatty liver disease in overweight children and adolescents. Acta Paediatr. 2007;96:1209-1213. [PMID: 17655622 DOI: 10.1111/j.1651-2227.2007.00399.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
165 Nelson RA, Bremer AA. Insulin resistance and metabolic syndrome in the pediatric population. Metab Syndr Relat Disord 2010;8:1-14. [PMID: 19943799 DOI: 10.1089/met.2009.0068] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
166 Procino F, Misciagna G, Veronese N, Caruso MG, Chiloiro M, Cisternino AM, Notarnicola M, Bonfiglio C, Bruno I, Buongiorno C, Campanella A, Deflorio V, Franco I, Guerra R, Leone CM, Mirizzi A, Nitti A, Osella AR; MICOL GROUP. Reducing NAFLD-screening time: A comparative study of eight diagnostic methods offering an alternative to ultrasound scans. Liver Int 2019;39:187-96. [PMID: 30248233 DOI: 10.1111/liv.13970] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
167 Alkhouri N, Carter-Kent C, Lopez R, Rosenberg WM, Pinzani M, Bedogni G, Feldstein AE, Nobili V. A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis. Clin Gastroenterol Hepatol. 2011;9:150-155. [PMID: 20888433 DOI: 10.1016/j.cgh.2010.09.015] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 4.9] [Reference Citation Analysis]
168 Purvis JW, Orandi BJ, Dhall D, McLeod C, Gutierrez Sanchez LH, Gray M, Frey K, Sheikh SS, Cannon RM, Terrault NA, Lewis CE, Locke JE. Hepatic macrosteatosis in the US pediatric deceased liver donor population. Pediatr Transplant 2021;:e14155. [PMID: 34590386 DOI: 10.1111/petr.14155] [Reference Citation Analysis]
169 Souza FIS, Amâncio OMS, Sarni ROS, Pitta TS, Fernandes AP, Fonseca FLA, Hix S. Doença hepática gordurosa não alcoólica em escolares obesos. Rev paul pediatr 2008;26:136-41. [DOI: 10.1590/s0103-05822008000200007] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
170 Hattar LN, Wilson TA, Tabotabo LA, Smith EO, Abrams SH. Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis. World J Gastroenterol 2011; 17(39): 4396-4403 [PMID: 22110265 DOI: 10.3748/wjg.v17.i39.4396] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
171 Nieminen P, Mustonen A, Kärjä V, Asikainen J, Rouvinen-watt K. Fatty Acid Composition and Development of Hepatic Lipidosis During Food Deprivation—Mustelids as a Potential Animal Model for Liver Steatosis. Exp Biol Med (Maywood) 2009;234:278-86. [DOI: 10.3181/0806-rm-210] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
172 Liu JQ, Zhang ZJ, Wang W, Lin KR, Liu G, Jiang CS, Chen ZP, Li HT, Lin WL. Risk factors for non-alcoholic fatty liver disease combined with type 2 diabetes mellitus in adolescents. Shijie Huaren Xiaohua Zazhi 2015; 23(11): 1812-1817 [DOI: 10.11569/wcjd.v23.i11.1812] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
173 Ooi SQ, Chan RM, Poh LK, Loke KY, Heng CK, Chan YH, Gan SU, Lee KO, Lee YS. Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children. Pediatr Obes 2014;9:81-91. [PMID: 23447513 DOI: 10.1111/j.2047-6310.2013.00149.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
174 Chaturvedi K, Vohra P. Non-alcoholic fatty liver disease in children. Indian Pediatr 2012;49:757-8. [DOI: 10.1007/s13312-012-0161-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
175 Soder RB, Baldisserotto M, da Silva VD. Computer-Assisted Ultrasound Analysis of Liver Echogenicity in Obese and Normal-Weight Children. American Journal of Roentgenology 2009;192:W201-5. [DOI: 10.2214/ajr.08.2061] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
176 Hatipoğlu N, Doğan S, Mazıcıoğlu MM, Kurtoğlu S. Relationship between Neck Circumference and Non-Alcoholic Fatty Liver Disease in Childhood Obesity. J Clin Res Pediatr Endocrinol 2016;8:32-9. [PMID: 26758497 DOI: 10.4274/jcrpe.2313] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
177 Gökçe S, Atbinici Z, Aycan Z, Çınar HG, Zorlu P. The Relationship Between Pediatric Nonalcoholic Fatty Liver Disease and Cardiovascular Risk Factors and Increased Risk of Atherosclerosis in Obese Children. Pediatr Cardiol 2013;34:308-15. [DOI: 10.1007/s00246-012-0447-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
178 Reinehr T, Schmidt C, de Sousa G, Andler W. Association between leptin and transaminases: 1-year follow-up study in 180 overweight children. Metabolism 2009;58:497-503. [DOI: 10.1016/j.metabol.2008.11.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
179 Rorat M, Jurek T, Kuchar E, Szenborn L, Golema W, Halon A. Liver steatosis in Polish children assessed by medicolegal autopsies. World J Pediatr. 2013;9:68-72. [PMID: 23275099 DOI: 10.1007/s12519-012-0387-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
180 Bahar A, Kashi Z, Sohrab M, Kosaryan M, Janbabai G. Relationship between beta-globin gene carrier state and insulin resistance. J Diabetes Metab Disord 2012;11:22. [PMID: 23497547 DOI: 10.1186/2251-6581-11-22] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
181 Pirgon O, Cekmez F, Bilgin H, Eren E, Dundar B. Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease. Obes Res Clin Pract. 2013;7:e275-e283. [PMID: 24306155 DOI: 10.1016/j.orcp.2012.01.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
182 Pirgon Ö, Bilgin H, Çekmez F, Kurku H, Dündar BN. Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol. 2013;5:33-39. [PMID: 23367495 DOI: 10.4274/jcrpe.825] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
183 Alkhouri N, Carter-Kent C, Elias M, Feldstein AE. Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease. Clin Lipidol. 2011;6:305-314. [PMID: 22162978 DOI: 10.2217/clp.11.19] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]